Royal Bank Of Canada Reiterates "Sector perform" Rating for Haleon (LON:HLN)

Key Points

• Haleon's stock has been given a "sector perform" rating by Royal Bank of Canada, with a price target of GBX 370 ($4.89), indicating a potential upside of 0.95% from its current price.
• The company reported quarterly earnings of GBX 8.90 ($0.12) per share, with analysts predicting a total of 19.50 earnings per share for the current fiscal year.
• Insider transactions include a purchase of 21,300 shares by Marie-Anne Aymerich and a sale of 64,329 shares by Dawn Allen, reflecting active insider engagement with the stock.

Haleon (LON:HLN - Get Free Report)'s stock had its "sector perform" rating reissued by analysts at Royal Bank Of Canada in a research note issued on Thursday, MarketBeat reports. They presently have a GBX 370 ($4.91) price objective on the stock. Royal Bank Of Canada's target price would suggest a potential upside of 1.14% from the stock's previous close.

Haleon Trading Up 1.8%

Shares of LON:HLN opened at GBX 365.83 ($4.86) on Thursday. The firm has a fifty day moving average of GBX 381.70 and a two-hundred day moving average of GBX 385.07. The firm has a market capitalization of £33.02 billion, a P/E ratio of 30.77, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. Haleon has a 12-month low of GBX 346.10 ($4.59) and a 12-month high of GBX 419.50 ($5.57). The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 53.36.

Haleon (LON:HLN - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported GBX 8.90 ($0.12) EPS for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. On average, equities analysts expect that Haleon will post 19.5033282 EPS for the current fiscal year.

Insider Transactions at Haleon

In related news, insider Blathnaid Bergin acquired 6,145 shares of the stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of GBX 404 ($5.36) per share, for a total transaction of £24,825.80 ($32,951.69). Also, insider Marie-Anne Aymerich bought 21,300 shares of the business's stock in a transaction that occurred on Friday, May 9th. The stock was purchased at an average price of GBX 405 ($5.38) per share, with a total value of £86,265 ($114,500.93). 10.74% of the stock is owned by corporate insiders.

Haleon Company Profile

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.